Medical devicemakers are tapping into electric fields as a new treatment for cancer, The Wall Street Journal reported May 16.
For decades, electricity has been used to treat cardiovascular conditions and serious mental illnesses, but companies are now pioneering how electric fields and pulses can be used in cancer care.
Novocure is one of those companies. It developed adhesive patches containing electrodes that deliver low-intensity, alternating electric fields to slow the growth of glioblastoma tumors. The 2.7-pound device, which is intended to be worn 18 hours a day, was FDA-approved in November.
Another recently approved device, TheraBionic P1, uses radiofrequency electromagnetic fields to target cancerous liver tumors. The at-home device is a spoon patients hold in their mouth for an hour while the device emits specific frequencies to block tumor growth and shrink tumors.
Read more here.
